Lambert Initiative for Cannabinoid Therapeutics.
Brain and Mind Centre, The University of Sydney.
Behav Pharmacol. 2020 Sep;31(6):591-596. doi: 10.1097/FBP.0000000000000565.
The major phytocannabinoid cannabidiol (CBD) has anxiolytic properties and lacks tetrahydrocannabinol-like psychoactivity. Cannabidiolic acid (CBDA) is the acidic precursor to CBD, and this compound appears more potent than CBD in animal models of emesis, pain and epilepsy. In this short report, we aimed to examine whether CBDA is more potent than CBD in disrupting expression of conditioned fear and generalised anxiety-related behaviour induced by Pavlovian fear conditioning. Mice underwent fear conditioning and 24 h later were administered CBD and CBDA before testing for fear expression and generalized anxiety-like behaviour. We found that CBD and CBDA had dissociable effects; while CBD but not CBDA disrupted cued fear memory expression, CBDA but not CBD normalized trauma-induced generalized anxiety-related behaviour. Neither phytocannabinoid affected contextual fear expression. Our findings form the basis for future experiments examining whether phytocannabinoids, alone and in combination, are effective in these mouse models of fear and anxiety.
主要的植物大麻素大麻二酚(CBD)具有抗焦虑特性,且没有类似四氢大麻酚的精神活性。大麻二酚酸(CBDA)是 CBD 的酸性前体,这种化合物在呕吐、疼痛和癫痫的动物模型中似乎比 CBD 更有效。在本简短报告中,我们旨在研究 CBDA 是否比 CBD 更能干扰由条件性恐惧引起的条件性恐惧和广泛性焦虑相关行为的表达,通过条件性恐惧形成进行测试。小鼠进行恐惧条件反射,24 小时后给予 CBD 和 CBDA,然后测试恐惧表达和广泛性焦虑样行为。我们发现 CBD 和 CBDA 具有可分离的作用;虽然 CBD 但不是 CBDA 干扰了条件性恐惧记忆的表达,但 CBDA 但不是 CBD 纠正了创伤引起的广泛性焦虑相关行为。两种植物大麻素都不影响情境恐惧表达。我们的研究结果为未来的实验奠定了基础,这些实验将单独和联合研究植物大麻素在这些恐惧和焦虑的小鼠模型中的有效性。